Hypofractionated Pencil-Beam Scanning Intensity-modulated Proton Therapy (IMPT) in Recurrent Rectal Cancer (IMPARC)
Hypofractionated Pencil-Beam Scanning Intensity-modulated Proton Therapy (IMPT) in the Reirradiation of Locoregionally Recurrent Rectal Cancer - IMPARC
Sponsor: Washington University School of Medicine
Terminated
Slow enrollment
Other terminated trials from Washington University School of Medicine
- Gynecologic Cancer · Phase NA · Oct 2025
- Extensive-stage Small Cell Lung Cancer · Phase PHASE2 · Aug 2025
- Schizophrenia · Phase PHASE1 · Jan 2025
- Systemic Lidocaine Improves Pain Control After Surgery by Attenuating the Systemic Inflammatory Response to Surgery · Phase PHASE4 · Dec 2024
- Small Cell Lung Carcinoma · Phase PHASE1 · Nov 2024
See all terminations from Washington University School of Medicine
This NA trial investigates Recurrent Rectal Cancer and is currently terminated or withdrawn. Washington University School of Medicine leads this study, which shows 15 recorded versions since 2021 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
15 versions recorded-
Oct 2025 — Present [monthly]
Terminated NA
-
Sep 2025 — Oct 2025 [monthly]
Terminated NA
-
Mar 2025 — Sep 2025 [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Feb 2025 — Mar 2025 [monthly]
Recruiting NA
-
Sep 2024 — Feb 2025 [monthly]
Recruiting NA
▶ Show 10 earlier versions
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Jun 2024 — Jul 2024 [monthly]
Recruiting NA
-
Sep 2023 — Jun 2024 [monthly]
Recruiting NA
-
Jun 2023 — Sep 2023 [monthly]
Recruiting NA
-
Mar 2023 — Jun 2023 [monthly]
Recruiting NA
-
Jan 2023 — Mar 2023 [monthly]
Recruiting NA
-
Dec 2021 — Jan 2023 [monthly]
Recruiting NA
-
Sep 2021 — Dec 2021 [monthly]
Recruiting NA
-
Jun 2021 — Sep 2021 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
May 2021 — Jun 2021 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Washington University School of Medicine
For direct contact, visit the study record on ClinicalTrials.gov .